Please download the dossier by clicking on the dossier button x
×

Method and composition for administering an NMDA receptor antagonist to a subject

  • US 7,619,007 B2
  • Filed: 11/22/2005
  • Issued: 11/17/2009
  • Est. Priority Date: 11/23/2004
  • Status: Active Grant
First Claim
Patent Images

1. A method of administering memantine to a human subject in need thereof, comprising 10-100 mg of:

  • orally administering to the human subject once per day over multiple days a sustained release oral dosage form comprising memantine or a pharmaceutically acceptable salt thereof and a component that sustains release of the memantine or salt thereof, wherein a therapeutically effective daily dose of the memantine or salt thereof is administered from initiation of therapy without prior dose escalation of memantine, and wherein the subject has a condition selected from the group consisting of Alzheimer'"'"'s disease, dementia, Parkinson'"'"'s disease, and neuropathic pain.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×